Venture Life Group (LON:VLG) Posts Quarterly Earnings Results

Venture Life Group (LON:VLG) announced its quarterly earnings data on Tuesday. The company reported GBX 4.10 earnings per share (EPS) for the quarter, Digital Look Earnings reports. Venture Life Group had a return on equity of 7.82% and a net margin of 17.42%.

Venture Life Group Stock Down 5.3%

Shares of Venture Life Group stock traded down GBX 3.63 on Tuesday, reaching GBX 64.57. The company’s stock had a trading volume of 917,310 shares, compared to its average volume of 272,819. Venture Life Group has a 52 week low of GBX 52 and a 52 week high of GBX 72. The firm’s fifty day simple moving average is GBX 67.59 and its two-hundred day simple moving average is GBX 65.13. The company has a quick ratio of 1.48, a current ratio of 4.71 and a debt-to-equity ratio of 0.82. The company has a market capitalization of £77.51 million, a price-to-earnings ratio of 14.78, a P/E/G ratio of 5.67 and a beta of 0.23.

Venture Life Group Company Profile

Venture Life is an international consumer self-care company focused on developing and commercialising products for the global self-care market helping our consumers live a longer healthier and more rewarding life.

Headquartered in the UK, the Group’s product portfolio includes Balance Activ in the area of women’s intimate healthcare, Earol® supporting ENT care, Lift and Glucogel product ranges for energy and glucose management and hypoglycaemia, plus the Health & Her product range supporting the hormonal lifecycle.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through health & beauty stores, pharmacies, grocery multiples and e-commerce channels and are sold globally.